Definitive Healthcare Q4 EPS Matches Estimates with 2.9% Surprise
Definitive Healthcare reported Q4 adjusted EPS of $0.06, matching estimates and surprising +2.92%, versus $0.08 a year ago, while revenue of $61.53M topped forecasts by 3.27% but dipped from $62.29M a year earlier. Shares have tumbled 50.9% year-to-date after four successive quarters of beating expectations.
1. Q4 Earnings and Revenue
Definitive Healthcare posted Q4 adjusted EPS of $0.06, matching consensus estimates and delivering a 2.92% earnings surprise compared with $0.08 per share a year earlier. Revenue reached $61.53 million, beating forecasts by 3.27% but down from $62.29 million in the prior year period.
2. Consistent Estimate Beats
The company has surpassed consensus EPS estimates in each of the last four quarters, including a 16.67% surprise in the previous period when it delivered $0.07 against a $0.06 estimate. These consecutive positive surprises highlight the company’s track record of modest outperformance.
3. Share Performance
Definitive Healthcare shares have declined 50.9% since the start of the year, significantly underperforming the S&P 500. The drop reflects investor concern over slowing revenue growth and pressure on profitability despite four straight quarters of earnings outperformance.
4. Outlook and Estimates
Analysts currently project EPS of $0.07 on $57.07 million in revenue for the upcoming quarter and full-year consensus forecasts of $0.26 in EPS on $233.37 million in revenue. These forecasts suggest limited near-term growth acceleration for the company.